Characterization of human and rat intestinal trefoil factor produced in yeast.
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.
Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells.
Trefoil peptides promote epithelial migration through a transforming growth factor 0-independent pathway.
Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.
Oral trefoil peptides protect against ethanol-induced and indomethacin-induced gastric injury in rats.
Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice.
Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.
B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.
Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat.
Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.